Literature DB >> 16631268

Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study.

Antoine Bruna1, Pauline Gastelblum, Laurence Thomas, Olivier Chapet, Marc A Bollet, Jean-Michel Ardiet, Jean-Pierre Gérard, Didier Peiffert.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate the results of pulsed dose rate brachytherapy (PDR) in SCACC.
MATERIAL AND METHODS: From 1996 to 2002, 71 patients (pts) with SCACC were treated with PDR brachytherapy. The median age was 61.2 years (35-88), with a sex ratio of 1 M/6.5 F. The TNM classification was: 14 T1, 41 T2, 15 T3 and 1 T4, 52 N0, 13 N1, 3 N2 and 3 N3. All the pts were M0. Treatment started with external beam irradiation to the posterior pelvis (mean dose: 45.5 Gy). Forty-seven patients received chemotherapy (neoadjuvant/concomitant or both). After an interval of 2-6 weeks, PDR interstitial brachytherapy was performed. The mean dose was 17.8 Gy to the 85% reference isodose of the Paris system.
RESULTS: Treatment was interrupted in only one pt. With a median follow-up of 28.5 months, 2-year actuarial overall survival was 90%. Fourteen relapses occurred (four distant, three regional, and seven local). Ten patients developed a grade III complication (Lent Soma scale) and two a grade IV complication (colostomy or abdominal perineal resection for necrosis).
CONCLUSION: PDR appears to be an effective treatment for SCACC. It is capable of reproducing the results usually observed with continuous LDR.

Entities:  

Mesh:

Year:  2006        PMID: 16631268     DOI: 10.1016/j.radonc.2006.03.013

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  9 in total

Review 1.  A review of the clinical experience in pulsed dose rate brachytherapy.

Authors:  Brian V Balgobind; Kees Koedooder; Diego Ordoñez Zúñiga; Raquel Dávila Fajardo; Coen R N Rasch; Bradley R Pieters
Journal:  Br J Radiol       Date:  2015-08-20       Impact factor: 3.039

Review 2.  Pulsed dose rate brachytherapy.

Authors:  A Polo
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

Review 3.  Squamous-cell carcinoma of the anus: progress in radiotherapy treatment.

Authors:  Rob Glynne-Jones; David Tan; Robert Hughes; Peter Hoskin
Journal:  Nat Rev Clin Oncol       Date:  2016-01-27       Impact factor: 66.675

4.  Interstitial high-dose rate brachytherapy as boost for anal canal cancer.

Authors:  Alexander Tuan Falk; Audrey Claren; Karen Benezery; Eric François; Mathieu Gautier; Jean-Pierre Gerard; Jean-Michel Hannoun-Levi
Journal:  Radiat Oncol       Date:  2014-11-06       Impact factor: 3.481

Review 5.  Pulsed dose rate brachytherapy - is it the right way?

Authors:  Janusz Skowronek
Journal:  J Contemp Brachytherapy       Date:  2010-10-13

6.  Pulse-dose-rate interstitial brachytherapy in anal squamous cell carcinoma: clinical outcomes and patients' health quality perception.

Authors:  Rémi Bourdais; Samir Achkar; Sophie Espenel; Sophie Bockel; Laetitia Chauffert-Yvart; Florence Ravet de Mellis; Minh-Hanh Ta; Wassila Boukhelif; Jérôme Durand-Labrunie; Pascal Burtin; Christine Haie-Meder; Eric Deutsch; Cyrus Chargari
Journal:  J Contemp Brachytherapy       Date:  2021-05-18

Review 7.  Sphincter preservation in anal cancer: a brief review.

Authors:  Divya Khosla; Ritesh Kumar; Rakesh Kapoor; Suresh C Sharma
Journal:  Saudi J Gastroenterol       Date:  2013 May-Jun       Impact factor: 2.485

Review 8.  Brachytherapy boost after chemoradiation in anal cancer: a systematic review.

Authors:  Rezarta Frakulli; Milly Buwenge; Silvia Cammelli; Gabriella Macchia; Eleonora Farina; Alessandra Arcelli; Martina Ferioli; Lorenzo Fuccio; Luca Tagliaferri; Andrea Galuppi; Giovanni P Frezza; Alessio G Morganti
Journal:  J Contemp Brachytherapy       Date:  2018-06-29

9.  Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal.

Authors:  Emilien Bertin; Karen Benezery; Daniel Lam Cham Kee; Eric François; Ludovic Evesque; Mathieu Gautier; Jean-Pierre Gerard; Jean-Michel Hannoun-Levi; Alexander T Falk
Journal:  J Contemp Brachytherapy       Date:  2018-12-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.